MaxCyte Inc (NASDAQ:MXCT) price on Wednesday, May 09, rose 18.07% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.64.
A look at the stock’s price movement, the close in the last trading session was $3.93. Turning to its 52-week performance, $5.55 and $2.45 were the 52-week high and 52-week low respectively. Overall, MXCT moved 11.81% over the past month.
MaxCyte Inc’s market cap currently stands at around $484.97 million.
Analysts have a consensus estimate of 11.34M for the company’s revenue for the quarter, with a low and high estimate of 6.1M and 7.92M respectively. The average forecast suggests up to a 32.30% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 34.22M, representing a -17.10% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MXCT is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
MXCT’s current price about 20.10% and 12.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 71.33, while 7-day volatility ratio is 10.04% and 5.64% in the 30-day chart. Further, MaxCyte Inc (MXCT) has a beta value of 0, and an average true range (ATR) of 0.25.
If we refocus on MaxCyte Inc (NASDAQ:MXCT), historical trading data shows that trading volumes averaged 550.35K over the past 3 months. The company’s latest data on shares outstanding shows there are 103.96 million shares.
The 12.19% of MaxCyte Inc’s shares are in the hands of company insiders while institutional holders own 72.28% of the company’s shares. Current price change has pushed the stock -1.28% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MXCT stock continues to rise going into the next quarter.
